Uladzislau Rudakou

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 10, 2026

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2026

Genome-wide association study of REM sleep behavior disorder in Parkinson's disease.

Genome-wide association study of REM sleep behavior disorder in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: June 30, 2025

Lack of epistatic interaction of SNCA with APOE in synucleinopathies.

Lack of epistatic interaction of SNCA with APOE in synucleinopathies.

Journal: Brain communications

Published: August 22, 2024

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia.

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia.

Journal: medRxiv : the preprint server for health sciences

Published: October 04, 2023

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 20, 2023

Genetic mechanism vs genetic subtypes: The example of GBA.

Genetic mechanism vs genetic subtypes: The example of GBA.

Journal: Handbook of clinical neurology

Published: February 21, 2023

NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.

NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.

Journal: Neurobiology of aging

Published: November 08, 2022

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.

Journal: Brain : a journal of neurology

Published: April 29, 2022

Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects.

Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects.

Journal: Nature communications

Published: February 16, 2022

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder.

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder.

Journal: Journal of Parkinson's disease

Published: October 25, 2021

New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin.

New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin.

Journal: Neuropharmacology

Published: June 28, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026